Valeant Pharmaceuticals International, Inc. (BHC)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
06-Oct-20 4:50 PM
View: 
Spurr Robert
President, Salix
Valeant Pharmaceuticals Int... (BHC) 02-Oct-20Payment of Exercise 276$15.89$4,385.64(< 1%)
38.97K to 38.7K
02-Oct-20 5:01 PM
View: 
de Schutter Richard U
Director
Valeant Pharmaceuticals Int... (BHC) 30-Sep-20Grant 2,171$15.54$33,737.30< 1%
307.23K to 309.4K
02-Oct-20 5:02 PM
View: 
Paulson John
Director
Valeant Pharmaceuticals Int... (BHC) 30-Sep-20Grant 1,930$15.54$29,992.203%
70.07K to 72.0K
02-Oct-20 5:03 PM
View: 
Robertson Russel C
Director
Valeant Pharmaceuticals Int... (BHC) 30-Sep-20Grant 2,413$15.54$37,498.002%
109.49K to 111.9K
02-Oct-20 5:03 PM
View: 
Wechsler Amy B
Director
Valeant Pharmaceuticals Int... (BHC) 30-Sep-20Grant 442$15.54$6,868.68< 1%
100.73K to 101.17K
16-Sep-20 4:06 PM
View: 
Herendeen Paul
EVP and CFO
Valeant Pharmaceuticals Int... (BHC) 15-Sep-20Payment of Exercise 1,642$15.91$26,124.20(< 1%)
300.25K to 298.61K
16-Sep-20 4:09 PM
View: 
Papa Joseph C
CHAIRMAN & CEO
Director
Valeant Pharmaceuticals Int... (BHC) 15-Sep-20Payment of Exercise 5,115$15.91$81,379.60(< 1%)
804.98K to 799.87K
16-Sep-20 4:09 PM
View: 
Papa Joseph C
CHAIRMAN & CEO
Director
Valeant Pharmaceuticals Int... (BHC) 14-Sep-20Payment of Exercise 3,623$15.40$55,794.20(< 1%)
808.6K to 804.98K
10-Sep-20 4:34 PM
View: 
Humphries William D.
President, Ortho-Dermatologics
Valeant Pharmaceuticals Int... (BHC) 08-Sep-20Sale (Planned) 5,667$16.17$91,635.40(2%)
240.7K to 235.03K
31-Aug-20 6:50 PM
View: 
Spurr Robert
President, Salix
Valeant Pharmaceuticals Int... (BHC) 28-Aug-20Payment of Exercise 1,278$17.00$21,726.00(3%)
40.25K to 38.97K
31-Aug-20 6:44 PM
View: 
Ackermann Christina
EVP and General Counsel
Valeant Pharmaceuticals Int... (BHC) 28-Aug-20Grant 28,171----29%
96.03K to 124.2K
19-Aug-20 7:12 PM
View: 
Humphries William D.
President, Ortho-Dermatologics
Valeant Pharmaceuticals Int... (BHC) 17-Aug-20Payment of Exercise 4,567$17.48$79,831.20(2%)
245.27K to 240.7K
02-Jul-20 4:35 PM
View: 
Robertson Russel C
Director
Valeant Pharmaceuticals Int... (BHC) 30-Jun-20Grant 2,050$18.29$37,494.502%
107.44K to 109.49K
02-Jul-20 4:39 PM
View: 
Wechsler Amy B
Director
Valeant Pharmaceuticals Int... (BHC) 30-Jun-20Grant 375$18.29$6,858.75< 1%
100.35K to 100.73K
02-Jul-20 4:25 PM
View: 
de Schutter Richard U
Director
Valeant Pharmaceuticals Int... (BHC) 30-Jun-20Grant 1,750$18.29$32,007.50< 1%
305.48K to 307.23K
02-Jul-20 4:30 PM
View: 
Paulson John
Director
Valeant Pharmaceuticals Int... (BHC) 30-Jun-20Grant 1,545$18.29$28,258.102%
68.52K to 70.07K
09-Jun-20 8:24 PM
View: 
Valueact Holdings, L.P.
Director
Valeant Pharmaceuticals Int... (BHC) 05-Jun-20Private Purchase 948,353$19.24$18,246,300.005%
17.93M to 18.88M
09-Jun-20 8:24 PM
View: 
Valueact Holdings, L.P.
Director
Valeant Pharmaceuticals Int... (BHC) 05-Jun-20Sale 948,353$19.24$18,246,300.00(5%)
18.88M to 17.93M
14-May-20 6:25 PM
View: 
Paulson John
Director
Valeant Pharmaceuticals Int... (BHC) 14-May-20Purchase 1,628,920$15.87$25,857,800.007%
24.21M to 25.84M
14-May-20 6:25 PM
View: 
Paulson John
Director
Valeant Pharmaceuticals Int... (BHC) 13-May-20Purchase 1,330,040$16.52$21,972,600.006%
22.88M to 24.21M
14-May-20 6:25 PM
View: 
Paulson John
Director
Valeant Pharmaceuticals Int... (BHC) 12-May-20Private Purchase 2,041,040$17.35$35,421,100.0010%
20.84M to 22.88M
06-May-20 4:02 PM
View: 
Papa Joseph C
CHAIRMAN & CEO
Director
Valeant Pharmaceuticals Int... (BHC) 04-May-20Payment of Exercise 95,489$17.16$1,638,590.00(11%)
904.09K to 808.6K
01-May-20 4:11 PM
View: 
de Schutter Richard U
Director
Valeant Pharmaceuticals Int... (BHC) 01-May-20Grant 11,037----4%
294.44K to 305.48K
01-May-20 4:21 PM
View: 
Kavanagh Sarah B
Director
Valeant Pharmaceuticals Int... (BHC) 01-May-20Grant 11,037----17%
64.38K to 75.42K
01-May-20 4:23 PM
View: 
Paulson John
Director
Valeant Pharmaceuticals Int... (BHC) 01-May-20Grant 11,037----19%
57.49K to 68.52K
01-May-20 4:15 PM
View: 
Karabelas Argeris N
Director
Valeant Pharmaceuticals Int... (BHC) 01-May-20Grant 11,037----16%
70.65K to 81.68K
01-May-20 4:26 PM
View: 
Power Robert N
Director
Valeant Pharmaceuticals Int... (BHC) 01-May-20Grant 11,037----13%
82.74K to 93.78K
01-May-20 4:32 PM
View: 
Ross Thomas W. Sr.
Director
Valeant Pharmaceuticals Int... (BHC) 01-May-20Grant 11,037----14%
79.24K to 90.28K
01-May-20 4:35 PM
View: 
von Eschenbach Andrew C.
Director
Valeant Pharmaceuticals Int... (BHC) 01-May-20Grant 11,037----59%
18.57K to 29.6K
01-May-20 4:30 PM
View: 
Robertson Russel C
Director
Valeant Pharmaceuticals Int... (BHC) 01-May-20Grant 11,037----11%
96.4K to 107.44K
01-May-20 4:43 PM
View: 
Wechsler Amy B
Director
Valeant Pharmaceuticals Int... (BHC) 01-May-20Grant 11,037----12%
89.32K to 100.35K
01-May-20 5:37 PM
View: 
Hale David Robert
Director
Valeant Pharmaceuticals Int... (BHC) 01-May-20Grant 11,037----< 1%
17.94M to 17.95M
01-May-20 5:37 PM
View: 
Hale David Robert
Director
Valeant Pharmaceuticals Int... (BHC) 29-Apr-20Payment of Exercise 624$18.11$11,300.60(< 1%)
17.94M to 17.94M
01-May-20 4:11 PM
View: 
de Schutter Richard U
Director
Valeant Pharmaceuticals Int... (BHC) 29-Apr-20Payment of Exercise 624$18.11$11,300.60(< 1%)
295.07K to 294.44K
02-Apr-20 4:24 PM
View: 
de Schutter Richard U
Director
Valeant Pharmaceuticals Int... (BHC) 31-Mar-20Grant 2,016$15.50$31,248.00< 1%
293.05K to 295.07K
02-Apr-20 4:26 PM
View: 
Paulson John
Director
Valeant Pharmaceuticals Int... (BHC) 31-Mar-20Grant 1,774$15.50$27,497.003%
55.71K to 57.49K
02-Apr-20 4:30 PM
View: 
Robertson Russel C
Director
Valeant Pharmaceuticals Int... (BHC) 31-Mar-20Grant 2,419$15.50$37,494.503%
93.98K to 96.4K
02-Apr-20 4:32 PM
View: 
Wechsler Amy B
Director
Valeant Pharmaceuticals Int... (BHC) 31-Mar-20Grant 443$15.50$6,866.50< 1%
88.87K to 89.32K
16-Mar-20 4:24 PM
View: 
Ross Thomas W. Sr.
Director
Valeant Pharmaceuticals Int... (BHC) 12-Mar-20Private Purchase 2,500$15.53$38,837.503%
76.74K to 79.24K
11-Mar-20 8:52 PM
View: 
Ackermann Christina
EVP and General Counsel
Valeant Pharmaceuticals Int... (BHC) 10-Mar-20Grant 4,390----5%
87.25K to 91.64K
11-Mar-20 8:52 PM
View: 
Ackermann Christina
EVP and General Counsel
Valeant Pharmaceuticals Int... (BHC) 10-Mar-20Purchase 4,390$18.25$80,105.605%
91.64K to 96.03K
11-Mar-20 8:50 PM
View: 
von Eschenbach Andrew C.
Director
Valeant Pharmaceuticals Int... (BHC) 10-Mar-20Private Purchase 1,100$18.18$19,996.306%
17.46K to 18.57K
11-Mar-20 8:47 PM
View: 
de Schutter Richard U
Director
Valeant Pharmaceuticals Int... (BHC) 10-Mar-20Private Purchase 3,800$18.26$69,377.401%
289.25K to 293.05K
11-Mar-20 8:54 PM
View: 
Appio Thomas
Pres&Co-Head Bausch&Lomb/Int'l
Valeant Pharmaceuticals Int... (BHC) 09-Mar-20Payment of Exercise 2,734$20.96$57,304.60(1%)
189.37K to 186.63K
(4%)
11-Mar-20 9:01 PM
View: 
Herendeen Paul
EVP and CFO
Valeant Pharmaceuticals Int... (BHC) 09-Mar-20Payment of Exercise 9,328$20.96$195,515.00(3%)
309.58K to 300.25K
(4%)
11-Mar-20 8:59 PM
View: 
Gordon Joseph F
Pres&Co-Head Bausch&Lomb/Int'l
Valeant Pharmaceuticals Int... (BHC) 09-Mar-20Payment of Exercise 2,239$20.96$46,929.40(3%)
81.8K to 79.56K
(4%)
11-Mar-20 8:55 PM
View: 
Eldessouky Sam
SVP, CHIEF ACCOUNTING OFFICER
Valeant Pharmaceuticals Int... (BHC) 09-Mar-20Payment of Exercise 1,749$20.96$36,659.00(2%)
82.8K to 81.05K
(4%)
11-Mar-20 8:52 PM
View: 
Ackermann Christina
EVP and General Counsel
Valeant Pharmaceuticals Int... (BHC) 09-Mar-20Payment of Exercise 3,343$20.96$70,069.30(4%)
90.59K to 87.25K
(4%)
11-Mar-20 9:03 PM
View: 
Papa Joseph C
CHAIRMAN & CEO
Director
Valeant Pharmaceuticals Int... (BHC) 09-Mar-20Payment of Exercise 18,488$20.96$387,508.00(2%)
922.58K to 904.09K
(4%)
11-Mar-20 8:47 PM
View: 
de Schutter Richard U
Director
Valeant Pharmaceuticals Int... (BHC) 03-Mar-20Market Purchase 5,000$23.08$115,415.002%
284.25K to 289.25K
(5%)